GlassScriptPhysician profile
Ashutosh Sharma
NPI 1841829595
$2,134.76
in general payments reported to CMS, 2019-2025
19 companies · $884 in 2025
The $884 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $171 · 2024: $1,079 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Education: $75.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,059.63 |
| Education | $75.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $299.37 | 2025 | Cardiomems, Assurity, Aveir |
| Amgen INC. | $272.01 | 2024 | Repatha |
| Abiomed | $249.72 | 2024-2025 | Impella |
| Chiesi USA, INC. | $195.15 | 2023-2025 | Kengreal, Cleviprex |
| Shockwave Medical, INC | $162.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.46 | 2023-2024 | Jardiance |
| Boston Scientific Corporation | $125.39 | 2025 | Emblem Mri S-Icd |
| Merck Sharp & Dohme LLC | $124.77 | 2024 | Winrevair |
| Biotronik INC. | $123.39 | 2024 | Amvia Edge |
| Pfizer INC. | $123.05 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $56.05 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.13 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $50.00 | 2024 | Eliquis |
| Medtronic, INC. | $48.77 | 2025 | Cobalt Dr Mri Surescan |
| Esperion Therapeutics, INC. | $46.16 | 2023 | Nexletol |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $23.88 | 2025 | |
| Terumo Medical Corporation | $22.13 | 2023 | Angio-Seal |
| Philips North America LLC | $14.15 | 2025 | Lm Accessories |
| Novo Nordisk INC | $14.02 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashutosh Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.